EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Comparative Efficacy of Cyclosporine 0.1% and Sodium Hyaluronate 0.1% in Moderate-to-Severe Dry Eyes

Vironika Agrawal, Nishant Kumar, Asif Shahnawaz

EyeQuest · 2024

DOI: 10.4103/equest.equest_18_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EyeQuest, 2024. Verfasst von Vironika Agrawal und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dry eye disease (DED) is accompanied by hyperosmolarity of the tear film and inflammation of the ocular surface, which in the long term is responsible for loss of goblet cells, instability of the tear film, and disturbed mucin expression.

Aim

We aimed to compare the efficacy of sodium hyaluronate (HA) 0.1% and cyclosporine 0.1% in treating moderate-to-severe DED in terms of ocular surface disease index (OSDI) score, tear film breakup time, and Schirmer’s test. Settings and Design: Hospital-based, randomized clinical trial. Materials and Methods: The study consisted of 90 patients with moderate-to-severe dry eye condition allotted to two groups A and B to receive either cyclosporine 0.1% twice or HA 0.1% thrice for a 6-month duration. In the first 4 weeks, these drugs were given along with carboxymethyl cellulose (0.5%) four times. OSDI, Schirmer’s test, and tear breakup time (TBUT) were performed at baseline visit and at 6 weeks, 3 months, and 6 months of treatment.

Results

In the primary analysis, the mean change from baseline in TBUT, Schirmer’s, and OSDI score was increased in both the groups ( P < 0.05), although no significant intergroup differences were observed at weeks 6 and 12. However, all these tests in the 0.1% cyclosporine group showed a significant tendency for better improvement at 6 months compared with the other group ( P < 0.05). No serious adverse events were observed.

Conclusion

Both cyclosporine 0.1% and HA 0.1% are effective in treating moderate-to-severe dry eye conditions, but comparatively, cyclosporine is superior than HA in the long run.

Zitieren

APA

Agrawal, V., Kumar, N., & Shahnawaz, A. (2024). Comparative Efficacy of Cyclosporine 0.1% and Sodium Hyaluronate 0.1% in Moderate-to-Severe Dry Eyes. EyeQuest. https://doi.org/10.4103/equest.equest_18_24

Vancouver

Agrawal V, Kumar N, Shahnawaz A. Comparative Efficacy of Cyclosporine 0.1% and Sodium Hyaluronate 0.1% in Moderate-to-Severe Dry Eyes. EyeQuest. 2024. doi:10.4103/equest.equest_18_24

BibTeX
@article{Agrawal2024,
  author = {Agrawal, Vironika and Kumar, Nishant and Shahnawaz, Asif},
  title = {Comparative Efficacy of Cyclosporine 0.1% and Sodium Hyaluronate 0.1% in Moderate-to-Severe Dry Eyes},
  journal = {EyeQuest},
  year = {2024},
  doi = {10.4103/equest.equest_18_24}
}
Kostenlos starten →